Granules India Limited has informed the Exchange regarding a press release dated February 03, 2022, titled "Granules Pharmaceuticals, Inc. receives ANDA approval for Bupropion Hydrochloride Extended-Release Tablets".
Press Release Feb 03 2022
Filed with NSE ·
6ix hasn’t read this filing yet.
Earlier from Granules India
- Press Release Jan 31 2022
- Press Release Jan 28 2022
- Press Release Dec 30 2021
- Press Release Dec 28 2021
- Press Release Sep 13 2021
Later from Granules India
- Press Release Mar 15 2022
- Press Release Mar 18 2022
- Press Release May 18 2022
- Press Release Aug 26 2022
- Press Release Aug 30 2022
Follow Granules India into a list and get an email when it puts out news.
Follow Granules India